日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

A bivalent lysine-acetylated small-molecule binding site in MYC

MYC 中的二价赖氨酸乙酰化小分子结合位点

Gupta, Dikshat G; Truica, Mihai I; Steffeck, Adam W T; Parker, J Brandon; Ryan, Daniel H; Pan, Hao; Yang, William; Lu, Xinyan; Unno, Kenji; Quan, Songhua; Elmashae, Ala A; Kerber, Megan M; Brookins, C Elysse; Han, Huiying; Dufficy, Mary Fiona; Shim, Jin-Gon; Lambert, Mahil; Ziarek, Joshua J; Chakravarti, Debabrata; Schiltz, Gary E; Abdulkadir, Sarki A

Selective targeting of Plasmodium falciparum Hsp90 disrupts the 26S proteasome.

选择性靶向恶性疟原虫 Hsp90 可破坏 26S 蛋白酶体

Mansfield Christopher R, Quan Baiyi, Chirgwin Michael E, Eduful Benjamin, Hughes Philip F, Neveu Gaëlle, Sylvester Kayla, Ryan Daniel H, Kafsack Björn F C, Haystead Timothy A J, Leahy James W, Fitzgerald Michael C, Derbyshire Emily R

Older adults with newly diagnosed high-risk/secondary AML who achieved remission with CPX-351: phase 3 post hoc analyses

老年新诊断高危/继发性 AML 患者接受 CPX-351 治疗后达到缓解:3 期事后分析

Lin, Tara L; Rizzieri, David A; Ryan, Daniel H; Schiller, Gary J; Kolitz, Jonathan E; Uy, Geoffrey L; Hogge, Donna E; Solomon, Scott R; Wieduwilt, Matthew J; Ryan, Robert J; Faderl, Stefan; Cortes, Jorge E; Lancet, Jeffrey E

CPX-351 (cytarabine and daunorubicin) Liposome for Injection Versus Conventional Cytarabine Plus Daunorubicin in Older Patients With Newly Diagnosed Secondary Acute Myeloid Leukemia

CPX-351(阿糖胞苷和柔红霉素)脂质体注射剂与传统阿糖胞苷联合柔红霉素治疗老年新诊断继发性急性髓系白血病患者的疗效比较

Lancet, Jeffrey E; Uy, Geoffrey L; Cortes, Jorge E; Newell, Laura F; Lin, Tara L; Ritchie, Ellen K; Stuart, Robert K; Strickland, Stephen A; Hogge, Donna; Solomon, Scott R; Stone, Richard M; Bixby, Dale L; Kolitz, Jonathan E; Schiller, Gary J; Wieduwilt, Matthew J; Ryan, Daniel H; Hoering, Antje; Banerjee, Kamalika; Chiarella, Michael; Louie, Arthur C; Medeiros, Bruno C